The chaperone activity of α‐synuclein: Utilizing deletion mutants to map its interaction with target proteins

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Proteins: Structure, Function, and Bioinformatics

• Publication date

  2012-05-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1002/prot.24028PMID 22274962
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• α-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation

  2011cited by this paper
• NMR spectroscopy of 14-3-3ζ reveals a flexible C-terminal extension: differentiation of the chaperone and phosphoserine-binding activities of 14-3-3ζ.

  2011cited by this paper
• PAMAM dendrimers as potential agents against fibrillation of alpha-synuclein, a Parkinson's disease-related protein.

  2009cited by this paper
• The thioflavin T fluorescence assay for amyloid fibril detection can be biased by the presence of exogenous compounds

  2009cited by this paper
• Monitoring the prevention of amyloid fibril formation by alpha-crystallin. Temperature dependence and the nature of the aggregating species.

  2007cited by this paper
• Monitoring the prevention of amyloid fibril formation by α‐crystallin

  2007cited by this paper
• Characterisation of amyloid fibril formation by small heat-shock chaperone proteins human alphaA-, alphaB- and R120G alphaB-crystallins.

  2007cited by this paper
• Characterisation of Amyloid Fibril Formation by Small Heat-shock Chaperone Proteins Human αA-, αB- and R120G αB-Crystallins

  2007cited by this paper
• Characterization of oligomers during alpha-synuclein aggregation using intrinsic tryptophan fluorescence.

  2006cited by this paper
• A precipitating role for truncated alpha-synuclein and the proteasome in alpha-synuclein aggregation: implications for pathogenesis of Parkinson disease.

  2005cited by this paper
• A Precipitating Role for Truncated α-Synuclein and the Proteasome in α-Synuclein Aggregation

  2005cited by this paper
• Conformational constraints for amyloid fibrillation: the importance of being unfolded.

  2004cited by this paper
• Neurodegenerative diseases caused by protein aggregation: a phenomenon at the borderline between molecular evolution and ageing.

  2004cited by this paper
• Amyloid Fibril Formation by Lens Crystallin Proteins and Its Implications for Cataract Formation*

  2004cited by this paper
• Impact of the acidic C-terminal region comprising amino acids 109-140 on alpha-synuclein aggregation in vitro.

  2004cited by this paper
• Interaction of the molecular chaperone alphaB-crystallin with alpha-synuclein: effects on amyloid fibril formation and chaperone activity.

  2004cited by this paper
• Interaction of the Molecular Chaperone αB-Crystallin with α-Synuclein: Effects on Amyloid Fibril Formation and Chaperone Activity

  2004cited by this paper
• Small Heat‐shock Proteins and Clusterin: Intra‐ and Extracellular Molecular Chaperones with a Common Mechanism of Action and Function?

  2003cited by this paper
• Lipid Binding Inhibits α-Synuclein Fibril Formation*

  2003cited by this paper
• Lipid binding inhibits alpha-synuclein fibril formation.

  2003cited by this paper
• Distinct Roles of the N-terminal-binding Domain and the C-terminal-solubilizing Domain of α-Synuclein, a Molecular Chaperone*

  2002cited by this paper
• Dependence of α-synuclein aggregate morphology on solution conditions

  2002cited by this paper
• Stress-induced aggregation profiles of GST-alpha-synuclein fusion proteins: role of the C-terminal acidic tail of alpha-synuclein in protein thermosolubility and stability.

  2002cited by this paper
• Rapid purification and analysis of alpha-synuclein proteins: C-terminal truncation promotes the conversion of alpha-synuclein into a protease-sensitive form in Escherichia coli.

  2002cited by this paper
• Structural and functional implications of C-terminal regions of alpha-synuclein.

  2002cited by this paper
• Dependence of alpha-synuclein aggregate morphology on solution conditions.

  2002cited by this paper
• Structural and Functional Implications of C-Terminal Regions of α-Synuclein†

  2002cited by this paper
• Intrinsic disorder and protein function.

  2002cited by this paper
• Rapid purification and analysis of α‐synuclein proteins: C‐terminal truncation promotes the conversion of α‐synuclein into a protease‐sensitive form in Escherichia coli

  2002cited by this paper
• Stabilization of Partially Folded Conformation during α-Synuclein Oligomerization in Both Purified and Cytosolic Preparations*

  2001cited by this paper
• In vitro filament-like formation upon interaction between lens α-crystallin and βL-crystallin promoted by stress

  2000cited by this paper
• Enhanced vulnerability to oxidative stress by alpha-synuclein mutations and C-terminal truncation.

  2000cited by this paper
• Chaperone‐like activity of synucleins

  2000cited by this paper
• Structural changes in α‐synuclein affect its chaperone‐like activity in vitro

  2000cited by this paper
• Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy.

  2000cited by this paper
• In vitro filament-like formation upon interaction between lens alpha-crystallin and betaL-crystallin promoted by stress.

  2000cited by this paper
• Wild-type but Not Parkinson's Disease-related Ala-53 → Thr Mutant α-Synuclein Protects Neuronal Cells from Apoptotic Stimuli*

  2000cited by this paper
• alpha-Synuclein shares physical and functional homology with 14-3-3 proteins.

  1999cited by this paper
• α-Synuclein Shares Physical and Functional Homology with 14-3-3 Proteins

  1999cited by this paper
• alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies.

  1998cited by this paper
• Accelerated in vitro fibril formation by a mutant α-synuclein linked to early-onset Parkinson disease

  1998cited by this paper
• Filamentous nerve cell inclusions in neurodegenerative diseases.

  1998cited by this paper
• Lens alpha-crystallin: chaperone-like properties.

  1998cited by this paper
• α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson’s disease and dementia with Lewy bodies

  1998cited by this paper
• Evidence that the precursor protein of non-A beta component of Alzheimer's disease amyloid (NACP) has an extended structure primarily composed of random-coil.

  1997cited by this paper
• NACP, a protein implicated in Alzheimer's disease and learning, is natively unfolded.

  1996cited by this paper
• Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease.

  1993cited by this paper

• Monomers, Dimers, and Oligomers of Pyroglutamate-Modified α‑Synuclein Fragments Exhibit Distinct Biophysical Characteristics

  2025cites this paper
• Prediction of protein interactions with function in protein (de-)phosphorylation

  2025cites this paper
• Common genetic risk for Parkinson's disease and dysfunction of the endo-lysosomal system

  2024cites this paper
• Astrocytes and Alpha-Synuclein: Friend or Foe?

  2023cites this paper
• Differential interactions of α-synuclein conformers affect refolding and activity of proteins.

  2022cites this paper
• The immunology of Parkinson’s disease

  2022cites this paper
• Astrocytes in Neurodegenerative Diseases: A Perspective from Tauopathy and α-Synucleinopathy

  2021cites this paper
• Neurons and Glia Interplay in α-Synucleinopathies

  2021cites this paper
• Similarity of the non-amyloid-β component and C-terminal tail of monomeric and tetrameric alpha-synuclein with 14-3-3 sigma

  2021cites this paper
• Astrocyte dysfunction in Parkinson's disease: from the perspectives of transmitted α-synuclein and genetic modulation

  2021cites this paper
• Overexpression of alpha-synuclein promotes both cell proliferation and cell toxicity in human SH-SY5Y neuroblastoma cells

  2020cites this paper
• An update on cellular and molecular determinants of Parkinson's disease with emphasis on the role of the retromer complex

  2020cites this paper
• Prion Efficiently Replicates in α-Synuclein Knockout Mice

  2019cites this paper
• α-Synuclein and astrocytes: tracing the pathways from homeostasis to neurodegeneration in Lewy body disease

  2019cites this paper
• Intrinsic disorder associated with 14-3-3 proteins and their partners.

  2019cites this paper
• Amyloid fibrils prepared using an acetylated and methyl amidated peptide model of the α-Synuclein NAC 71–82 amino acid stretch contain an additional cross-β structure also found in prion proteins

  2019cites this paper
• The many faces of amyloid fibres: their detection and regulation by molecular chaperone proteins

  2017cites this paper
• The functional roles of the unstructured N- and C-terminal regions in αB-crystallin and other mammalian small heat-shock proteins

  2017cites this paper
• ALPHA-SYNUCLEIN STRUCTURE, AGGREGATION AND MODULATORS

  2016cites this paper
• Novel insights into the function of the conserved domain of the CAP superfamily of proteins

  2016cites this paper
• Role of autophagy in arsenite-induced neurotoxicity: the involvement of α-synuclein.

  2015cites this paper
• Lysosomal degradation of alpha-Synuclein: Analysis in vivo and in vitro

  2015cites this paper
• Experimental and computational analysis of the synucleins

  2014cites this paper
• Dopamine-Induced α-Synuclein Oligomers

  2014cites this paper
• Physicochemical Properties of Cells and Their Effects on Intrinsically Disordered Proteins (IDPs)

  2014cites this paper
• Effects of fusion with an unstructured and hyper-acidic polypeptide on the nature of recombinant proteins expressed in bacteria

  2013cites this paper
• Alpha-synuclein promotes early neurite outgrowth in cultured primary neurons

  2013cites this paper
• γ-synuclein is a novel player in the control of body lipid metabolism

  2013cites this paper
• Chaperones: General Characteristics and Classifications

  2013cites this paper
• Over‐expression of heat shock factor 1 phenocopies the effect of chronic inhibition of TOR by rapamycin and is sufficient to ameliorate Alzheimer's‐like deficits in mice modeling the disease

  2013cites this paper
• The mysterious C-terminal tail of alpha-synuclein: nanobody's guess.

  2013cites this paper
• From α-synuclein to synaptic dysfunctions: new insights into the pathophysiology of Parkinson's disease.

  2012cites this paper
• Conditional disorder in chaperone action.

  2012cites this paper
• Conditional Disorder in Chaperone Action Protein Disorder: a Fuzzy Concept Nih Public Access Author Manuscript Is Protein Disorder the Default? Conditionally Disordered Proteins Atp-independent Chaperones: Activation by Stress-induced Unfolding the Role of Intrinsic Disorder in Small Heat Shock Prot

  year unknowncites this paper